Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sri Obulareddy

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentCOM | Internal Med Hem-Onc
Address4301 W Markham
Little Rock AR 72205
ORCID ORCID Icon0000-0003-3636-0254 Additional info
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    PROTOCOL A012103     (OBULAREDDY, SRI)Dec 19, 2023 - Dec 18, 2033
    Alliance for Clinical Trials in Oncology
    276249 Alliance A012103, OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
    Role: Principal Investigator
    PROTOCOLA012103     (OBULAREDDY, SRI)Dec 19, 2023 - Dec 18, 2033
    Alliance for Clinical Trials in Oncology
    276249 Alliance A012103, OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
    Role: Principal Investigator
    PROTOCOL A011801     (OBULAREDDY, SRI)Dec 18, 2023 - Dec 17, 2033
    Alliance for Clinical Trials in Oncology
    276250 Alliance A011801,COMPASSHER2 Trials:COMPASSHER2 Residual Disease, A Double-Blinded, Phase III Randomized Trial of T-DM1&Placebo Compared with T-DM1 and Tucatinib
    Role: Principal Investigator
    PROTOCOLA011801     (OBULAREDDY, SRI)Dec 18, 2023 - Dec 17, 2033
    Alliance for Clinical Trials in Oncology
    276250 Alliance A011801,COMPASSHER2 Trials:COMPASSHER2 Residual Disease, A Double-Blinded, Phase III Randomized Trial of T-DM1&Placebo Compared with T-DM1 and Tucatinib
    Role: Principal Investigator
    PROTOCOL S2212     (OBULAREDDY, SRI)Jul 21, 2023 - Jul 20, 2033
    SouthWest Oncology Group
    276883 S2212, Shorter Anthracycline-Free Chemo Immunotherapy Adapted Topathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study
    Role: Principal Investigator
    PROTOCOLS2212     (OBULAREDDY, SRI)Jul 21, 2023 - Jul 20, 2033
    SouthWest Oncology Group
    276883 S2212, Shorter Anthracycline-Free Chemo Immunotherapy Adapted Topathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. McGoogan KE, Haafiz AB, Gonz?lez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011 Oct; 159(4):608-11. PMID: 38539487.
      View in: PubMed
    Co-Authors Expand Description
    See all (8) people
    _
    Same Department Expand Description
    Search Department